Navigation Links
Bayer Foundation Grant Creates Graduate Engineering Fellowship at University of Houston
Date:10/18/2007

PITTSBURGH, Oct. 18 /PRNewswire-USNewswire/ -- The Bayer Foundation announced today it has awarded a $90,000 grant to the University of Houston's Department of Chemical & Biomolecular Engineering (UH CHBE) to establish the Bayer Graduate Fellowship Program.

The fellowship, which is competitive with other prestigious fellowships from the National Science Foundation and elsewhere, will be awarded over a three-year period to a graduate student pursuing a doctoral degree in chemical engineering. The recipient will be identified from a pool of second year students seeking to complete his/her studies.

"We are extremely pleased to make this gift to the University of Houston, an institution whose chemical and biomolecular engineering department is consistently placed among the top echelon in the United States for the quality of its faculty, their scholarship and research projects, as well as the quality and number of Ph.D. engineering students it graduates each year," said Willy Scherf, President and CEO, Bayer Corporate and Business Services LLC.

According to UH's CHBE, the department graduates nearly one Ph.D. student per year per faculty member. Presently, there are 14 full-time faculty members in the department.

"As a leading producer of polymers and high-performance plastics, we at Bayer MaterialScience are also impressed with the department's particular strengths in the areas of chemical reaction engineering, process engineering and control, and mathematical modeling," said Gregory S. Babe, President and CEO, Bayer MaterialScience LLC. "We are very aware of the fact that the growth of biotechnology and materials, including polymeric and bio- or plant-based materials, is producing a new group of graduates highly skilled in specialty products spanning polymers and biomaterials and that many of these graduates are coming out the University of Houston CHBE program."

Both Bayer MaterialScience and Bayer Corporate and Business Servi
'/>"/>

SOURCE Bayer Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Bayer Voluntarily Withdraws BAYCOL - A Drug Associated With 50 Deaths
2. Bayer Wins Positive Response For Marketing Its Cancer Drug
3. Genomatix Licensed By Bayer Healthcare
4. Bayer to Market Biocon Insulin in China
5. Test for Esophageal Reflux Licensed to Bayer by University
6. Bayer and Onyx Submit Supplemental New Drug Application for Nexavar to Treat Liver Cancer
7. Dow Acquires Wolff Walsrode from Bayer
8. Woodruff Foundation Grant To Support Doctorate Of Nursing Practice Program
9. Kalam To Lay Foundation Of Vellore Research Center
10. Nippon Foundation To Help Leprosy Patients
11. Parents Launch SV40 Cancer Foundation In Memory of Son

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...TON, N.J., Nov. 27 The diabetes po...ver the next 25 years and annual medical spending ...p from $113 billion today, according to a study pu... The National Changing Diabetes ® Program (N...analysis by a team from the University of Chicago....
(Date:11/26/2009)...ering drug tetrathiomolybdate (TM) has been shown ...son disease, a disease caused by an overload of co... known. Very little, however, is known about how t...udy led by Northwestern University researchers now...ional structure of TM bound to copper-loaded metal...
(Date:11/26/2009)...rill when on an emotional rollercoaster, study fin...) -- Call it the fear factor meets the jubilant sp...s -- especially those who root for the winning tea...sely contested match and victory was in doubt, pro...ew on that this Thanksgiving weekend as you,re glu...
(Date:11/26/2009)... Dr. David Kim of the Live Life Again Center,...s , is one of a growing number of physicians who a...sites to connect with individuals who are interest...id obesity. Dr. Kim is utilizing Facebook to share... practice with the community. , ...
(Date:11/26/2009)... Benton Communications announces a highly eff...or retailers struggling to make an economic recove..., 2009 -- Flu fears is the type of challenge that ...oom, according to Dr. David Benton, business growt... growth system – The Rfactor Intensive . ...
Breaking Medicine News(10 mins):Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Pharmacist Injects Cure for Ailing Businesses 2
... More than 1,500 CME Sessions Viewed at www.Card...une 2009 , Boston, MA (PR...gural online medical conference for physicians and...ation , which includes video webcasts and a facul...
...nt adoption of programs designed to improve health... April 2 CVS Caremark (NYSE: CVS ) today announ...hat a majority of the company,s employer clients s... by simply shifting costs to the member. In fact,...
...AS, Inc. (Nasdaq: AMCS ) a leader in radiology a...ons, today announced the successful completion of ...ICAS Acquisition Corp. for shares of common stock ...wscom.com/cgi-bin/prnh/20060202/AMICASLOGO ) , ...
...Endoscopy, Inc. (OTC Pink Sheets: SNDY) is pleased...endocoupler with an eye piece for the MammoView(TM...will allow the MammoView scope to be used by a maj...could not utilize the standard endocoupler. The n...
...ril 2, 2009 AMERIGROUP Corporation (NYSE: AGP...s for the first quarter ended March 31, 2009, at a... 1, 2009. At 8:30 a.m. Eastern Time on the same d...0-3161 (domestic) or 706-679-7245 (international) ...
... Slow, Hospitals and Treatment Centers Seek Compet...NTA, April 2 For oncology programs struggling to ...s appealing. The pressure to gain efficiencies com...al push to implement electronic medical records (E...
Other Medicine News:Health News:CardioCareLive.com, First Ever Online Cardiometabolic Conference, Revolutionizes Continuing Medical Education for Cardiovascular Healthcare Professionals 2Health News:CVS Caremark Announces Results of Annual Employer Survey Validating Proactive Pharmacy Care Approach 2Health News:CVS Caremark Announces Results of Annual Employer Survey Validating Proactive Pharmacy Care Approach 3Health News:CVS Caremark Announces Results of Annual Employer Survey Validating Proactive Pharmacy Care Approach 4Health News:AMICAS Successfully Completes Tender Offer for Shares of Emageon Inc. 2Health News:Solos Endoscopy, Inc. Develops Specialized Endocoupler for the MammoView(TM) 2Health News:AMERIGROUP Corporation to Discuss First Quarter Earnings on May 1 2Health News:Hospitals Turn to Vendors Like Elekta for Help in Squeezing Most From Existing Technologies 2Health News:Hospitals Turn to Vendors Like Elekta for Help in Squeezing Most From Existing Technologies 3
(Date:11/25/2009)... Swissray International, Inc. a lea...ddR ) systems, announced today that its operations...th a long term view towards growing Swissray,s med...ssets and intellectual property, as well as contra...rowth Swissray is now poised to move to the next l...
(Date:11/25/2009)...RNewswire/ -- Cempra Pharmaceuticals Inc. today an...chief executive officer, will present at the Piper...0 a.m. EST, December 1, 2009, at The New York Pala...vide an overview of the company,s two leading anti...-resistant pathogens including MRSA. ,, About ...
(Date:11/25/2009)... JOHANNESBURG, November 25 ,iThemba...very announced today,that they have signed a colla...s, services. , Pyxis,s world class comput...l be coupled with iThemba,s service division to pr... projects identified through Pyxis,international ...
Breaking Medicine Technology:Swissray International Announces New Ownership 2iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Cellular Technology Extends the Boundaries of E healthcare Says Frost 26 Sullivan 50367 1Cellular Technology Extends the Boundaries of E healthcare Says Frost 26 Sullivan 50367 2Cellular Technology Extends the Boundaries of E healthcare Says Frost 26 Sullivan 50367 3Study to see if video games can boost thinking skills in elderly 50364 1Study to see if video games can boost thinking skills in elderly 50364 2Asia Debut for Money Saving Pharma Packaging Machines from Ireland 12839 1Asia Debut for Money Saving Pharma Packaging Machines from Ireland 12839 2Asia Debut for Money Saving Pharma Packaging Machines from Ireland 12839 3
... Bleeding in Patients Treated for Acute Coronary S... One Year, NEW ORLEANS, March 26, 2007 /PRNewswire...ial show that acute coronary syndrome,(ACS) patien...ent,group had similar rates of ischemic clinical o...erapy, confirming previous findings,which showed ...
...al Analysis Shows Statistically Significant Change..., Calif., March 26, 2007 /PRNewswire-FirstCall/ --...tive initial,results from its Phase IIa clinical t...enic patients with acute agitation. The 10 mg,dose...l trial,which was a statistically-significant red...
Other Medicine Technology:Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 2Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 3Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 4Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 5Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 6Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 2Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 3Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 4Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 5Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 6
...ted Aumated Immunoassay Analyzer that fits in any ...16 X 16 X 21 inches and weighs approximately 60 lb...e laboratories, work stations for small hospitals,...a dedicated system for specialty testing. With a t...
...automation and continuous random access capabiliti...ssays for thyroid, anemia, cardiac, reproductive, ...g are currently available, with infectious disease...ltaneously process 60 accessible samples for a thr...
...tic Drug Monitoring Market in 1981 with the introd... uses technology known as FPIA (Fluorescence Polar...ration in a patient. Therapeutic Drugs, used in th... narrow therapeutic range requiring close monitori...
Architect i2000
Medicine Products: